IDEAS home Printed from https://ideas.repec.org/p/ohe/conrep/001660.html
   My bibliography  Save this paper

Data Governance Arrangements for Real-World Evidence

Author

Listed:
  • Cole, A.
  • Garrison, L.
  • Mestre-Ferrandiz, J.
  • Towse, A.

Abstract

The objective of this OHE Consulting Report was to understand and develop a view on the core principles that should govern how Real-World Data (RWD) is accessed or generated, and used credibly to produce or generate Real-World Evidence (RWE), thereby working toward a set of "international standards". In this report, we firstly outline models of data governance in eight key markets - the UK, France, Italy, Sweden, Germany, the Netherlands, Australia and the U.S. With the insights generated from these case studies, we then develop an illustrative framework of a top-performing governance model. By defining this model, we provide recommendations of what constitutes a good governance framework, which will support the favourable environment for the creation of RWE.

Suggested Citation

  • Cole, A. & Garrison, L. & Mestre-Ferrandiz, J. & Towse, A., 2015. "Data Governance Arrangements for Real-World Evidence," Consulting Reports 001660, Office of Health Economics.
  • Handle: RePEc:ohe:conrep:001660
    as

    Download full text from publisher

    File URL: https://www.ohe.org/system/files/private/publications/420%20-%20Data%20Governance%20for%20RWE.pdf
    Download Restriction: no

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cole, A. & Towse, A., 2018. "Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation," Consulting Reports 002096, Office of Health Economics.
    2. Jorge Mestre-Ferrandiz & Néboa Zozaya & Bleric Alcalá & Álvaro Hidalgo-Vega, 2018. "Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?," PharmacoEconomics, Springer, vol. 36(12), pages 1407-1420, December.

    More about this item

    Keywords

    Economics of innovation; Judging value for money and improving decision making; Measuring and valuing outcomes;

    JEL classification:

    • I1 - Health, Education, and Welfare - - Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ohe:conrep:001660. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Publications Manager). General contact details of provider: http://edirc.repec.org/data/ohecouk.html .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.